Matches in Nanopublications for { ?s ?p "[Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP787103.RADZgl9FQOX5Zg7UXaTaAPZIKqWtsIekDqre7vuMD1ZnU130_assertion description "[Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP787103.RADZgl9FQOX5Zg7UXaTaAPZIKqWtsIekDqre7vuMD1ZnU130_provenance.
- assertion description "[Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP749988.RAka9TUlLB0hzbKRqTcYLDeXLcNyqMr99nAsu6QYoNEb0130_assertion description "[Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP749988.RAka9TUlLB0hzbKRqTcYLDeXLcNyqMr99nAsu6QYoNEb0130_provenance.
- NP297098.RA3vUklKma1mCGaimlq2OKQFU8u52e7cfQpv_ol4mQslA130_assertion description "[Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP297098.RA3vUklKma1mCGaimlq2OKQFU8u52e7cfQpv_ol4mQslA130_provenance.
- NP426972.RAqlDP1aWj-kze0qizIuKvtqFH8qA3YHPZIUZwarwfVXU130_assertion description "[Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP426972.RAqlDP1aWj-kze0qizIuKvtqFH8qA3YHPZIUZwarwfVXU130_provenance.
- NP426977.RAyrhLEPcD0eCC0vyXuHEPN6-CyBlnzjEe2uwSySnTBKg130_assertion description "[Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP426977.RAyrhLEPcD0eCC0vyXuHEPN6-CyBlnzjEe2uwSySnTBKg130_provenance.
- NP925948.RAObhXhFn9AMn8R3Qu94XJruM4bYxWUpJmtB6dTh4n-eI130_assertion description "[Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925948.RAObhXhFn9AMn8R3Qu94XJruM4bYxWUpJmtB6dTh4n-eI130_provenance.
- NP925944.RAy4Dhv_N_aVJ8v8TvrRHYqRtPlU17CaHY7unJxcAziiE130_assertion description "[Advances in liver cancer antibody therapies: a focus on glypican-3 and mesothelin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925944.RAy4Dhv_N_aVJ8v8TvrRHYqRtPlU17CaHY7unJxcAziiE130_provenance.